AFP-L3

There are 7 papers on AFP-L3 in aging research: 1 trial and 3 observational studies in people, 3 reviews.

7 papers study it2 more mention it1 finding

See all 9 papers on AFP-L3

Human trial1
Humans3

Associations

1

Hepatocellular carcinoma

upin humans1

1 study

AFP-L3 predicts hepatocellular carcinoma in humans (diagnosis of hepatocellular carcinoma) (AUC 0.90 (95% CI: 0.87-0.92)).
“The estimated area under the curve (AUC) was 0.90 (95% CI: 0.87-0.92).”
Reviewdiagnosis of hepatocellular carcinoma
Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size
AgingMar 20, 2022

More on Hepatocellular carcinoma

Latest

8 papers in 12 months

Advances in Laboratory MedicineMar 19

Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients

Cohort study of 30 peopleHepatocellular carcinoma

Liver InternationalMar 13

Hepatocellular Carcinoma in Egypt in the Post HCV Elimination Era: Changing Aetiology, Surveillance, and Management Pathways

ReviewHepatocellular carcinoma

Clinical and Molecular HepatologyFeb 26

GAFAD: A liquid chromatography-tandem mass spectrometry-based model for early hepatocellular carcinoma detection beyond GALAD's limitations

Cohort study in peopleHepatocellular carcinoma

ClinicsFeb 19

Validation of the GALAD model for diagnosing HBV-related hepatocellular carcinoma in Chinese patients

Cohort study of 247 peopleBiomarkers

World Journal of GastroenterologyFeb 16

Refining early detection of hepatocellular carcinoma: The promise of the GALAD score

CommentaryHepatocellular carcinoma

GastroenterologyJan 20

Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial

Randomized trial in 1,208 peopleHepatocellular carcinoma

AgingMar 22

Clinical utility of serum fucosylated fraction of alpha-fetoprotein in the diagnostic of hepatocellular carcinoma: a comprehensive analysis with large sample size

Meta-analysisHepatocellular carcinoma

Molecular BiomedicineMar 11

Development and validation of a high-confidence diagnostic model integrating ctDNA methylation and serum biomarkers for early-stage hepatocellular carcinoma detection

Cohort study of 1,692 peopleHepatocellular carcinoma

Liver CancerFeb 2

Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel

ReviewHepatocellular carcinoma